# Pomerantz LLP

Type: Company

Source: GetYourBrief — https://getyourbrief.com/entity/pomerantz-llp
Canonical HTML page: https://getyourbrief.com/entity/pomerantz-llp

## Timeline

- **2026-Q3**: Initial Court Hearings — Expected timeframe for motions to dismiss and initial discovery phases in the respective district courts.
- **2026-Q3**: Discovery Phase — Expected commencement of the discovery process if the cases survive initial motions to dismiss.
- **2026-06-11**: Pomerantz LLP Announces Investigations — Pomerantz issues press releases for all five companies, seeking lead plaintiffs for potential securities class actions.
- **2026-06-11**: Pomerantz announces class actions — Pomerantz issued press releases notifying investors of filed lawsuits and upcoming lead plaintiff deadlines.
- **2026-06-04**: Celsius Texas AG Investigation — Texas AG Paxton announces investigation into Celsius's marketing of high-caffeine drinks to children. Stock falls 7.53%.
- **2026-06-03**: Compass Antitrust Probe Disclosure — Media reports NY AG antitrust investigation into Compass's $1.6B acquisition of Anywhere Real Estate. Stock falls 11.82%.
- **2026-06-01**: Wise Money Laundering Report — The Bureau of Investigative Journalism reports Belgian probe into Wise accounts used for money laundering. Stock falls 4.63% on June 2.
- **2026-05-28**: Photronics Q2 Earnings Miss — Photronics reports Q2 revenue of $209M, down YoY, and operating margin contraction. Stock falls 36.4%.
- **2026-05-28**: Gap Inc. Q1 Earnings Miss — Gap reports Q1 revenue of $3.5B, 1% growth YoY, missing estimates; cuts full-year guidance. Stock falls 15.4% on May 29.
- **2026-05-26**: Verra Mobility contract termination disclosure — Received Avis Budget Group termination notice effective Sep 2026; revised 2026 outlook downward; cost cuts planned. Stock crashed 70.57% to $3.85 on May 27.
- **2026-05-22**: Lead Plaintiff Deadline — Expected deadline for shareholders to petition the court to serve as lead plaintiff in the case.
- **2026-05-21**: Lead Plaintiff Deadline — Estimated 60-day deadline for investors to file motions to be appointed as lead plaintiff in the class actions.
- **2026-05-19**: Lead Plaintiff Deadline — Estimated deadline for shareholders to petition the court to lead the litigation.
- **2026-05-05**: Lead Plaintiff Deadline — Final date for investors to apply for lead plaintiff status in the litigation.
- **2026-05-05**: Lead Plaintiff Deadline — Final date for shareholders to move the court to serve as lead plaintiff in the litigation.

## Recent coverage (20 stories, network-wide)

### BitGo Stock Tumbles 6% as Securities Class Action Hits Crypto Custody Giant
2026-08-01 20:36:54 · Sector: crypto · Sentiment: Neutral · Impact: 5/10 · Sources: 2

A newly filed securities class action against BitGo Holdings threatens the crypto custodian's market standing. The lawsuit, alleging misstatements in its IPO documents, has already knocked 6% off BTGO shares and could shake institutional trust in digital asset infrastructure.
Full story: https://getcryptobrief.com/story/bitgo-class-action-crypto-custody-stock-fall

### Celcuity Stock Tanks 17.6% on Late Q3 Cancer Drug Launch; Pomerantz Investigates
2026-07-20 12:39:55 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 1

Pomerantz LLP probes Celcuity after FDA-approved breast cancer therapy Revtorpyk sees delayed Q3 2026 commercial launch, sending shares down 17.6%. Analysts question prior launch readiness; health investors weigh biotech regulatory and execution risks.
Full story: https://gethealthbrief.com/story/celcuity-revtorpyk-launch-delay-pomerantz-investigation

### GeneDx Impairment Sparks Biotech Securities Suit: $31.3M Charge on AI Acquisition
2026-06-15 03:31:31 · Sector: bio · Sentiment: Negative · Impact: 6/10 · Sources: 6

A $31.3 million impairment on the Fabric Genomics deal has drawn a securities lawsuit against GeneDx. For biotech investors, the case highlights the perils of overvalued AI acquisitions in genomics, as GeneDx trimmed its revenue forecast by up to $80 million.
Full story: https://getbiobrief.com/story/genedx-securities-lawsuit-bio-impairment

### 5 Securities Class Actions Filed: Pomerantz Targets HELE, PICS, BMI, VRRM, WGS with August Deadlines
2026-06-15 03:29:18 · Sector: legal · Sentiment: Negative · Impact: 6/10 · Sources: 6

Pomerantz LLP has filed suits against five public companies, alleging securities fraud following dramatic stock declines. With lead plaintiff deadlines in early August 2026, investors must act quickly to recover losses. The cases spotlight disclosure lapses in industries from consumer goods to biotech.
Full story: https://getlegalbrief.com/story/pomerantz-files-5-class-actions-august-deadlines

### Compass $1.6B Anywhere Deal Faces NY Antitrust Probe; Stock Slides 11.82%
2026-06-15 03:13:58 · Sector: proptech · Sentiment: Negative · Impact: 6/10 · Sources: 5

New York's antitrust investigation into Compass's $1.6 billion acquisition of Anywhere Real Estate has triggered a securities fraud probe by Pomerantz, after the stock plunged 11.82%. The scrutiny could reshape consolidation in residential real estate technology.
Full story: https://getproptechbrief.com/story/compass-1-6b-anywhere-real-estate-antitrust-probe-pomerantz

### Pomerantz Triggers 5 Securities Probes After 36.4% Photronics Plunge Leads Wave
2026-06-15 03:13:46 · Sector: legal · Sentiment: Negative · Impact: 6/10 · Sources: 5

Pomerantz LLP launched five securities fraud investigations on a single day, citing stock drops following adverse events. The Compass probe uniquely intertwines antitrust and securities law, while Photronics’ 36.4% crash raises classic disclosure concerns.
Full story: https://getlegalbrief.com/story/pomerantz-securities-fraud-investigations-compass-photronics-celsius-gap-wise

### $2.3B Market Value Erased in 5 Stock Crashes Triggering Pomerantz Probes
2026-06-15 03:13:33 · Sector: finance · Sentiment: Negative · Impact: 6/10 · Sources: 5

Investors in five companies—Compass, Photronics, Celsius, Gap, and Wise—suffered deep one-day losses, collectively wiping out billions, as negative news spurred Pomerantz investigations. The event underscores latent legal risk embedded in equity holdings.
Full story: https://getfinancebrief.com/story/pomerantz-investigations-prompt-market-value-loss-compass-photronics

### Navan Beats Q4 Expectations Amid AI Pivot and Legal Headwinds
2026-03-26 06:08:48 · Sector: hr · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Navan reported a surprise profit in Q4 2026, with revenue reaching $178 million and a positive EPS of $0.02. The company is doubling down on AI-driven travel management and expects 24% growth in 2027, despite ongoing investor litigation.
Full story: https://gethrbrief.com/story/navan-q4-2026-earnings-analysis-ai-travel

### Boston Scientific Faces Class Action Scrutiny Over Securities Disclosures
2026-03-23 23:33:15 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has initiated a class action lawsuit against Boston Scientific (BSX), alleging potential violations of federal securities laws. The litigation centers on the company's disclosures during a period of significant expansion and product integration, marking a critical legal challenge for the medical device giant.
Full story: https://getbiobrief.com/story/boston-scientific-class-action-pomerantz-llp

### Boston Scientific Faces Class Action Scrutiny Over Alleged Disclosure Failures
2026-03-23 23:32:10 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has initiated a class action investigation and filing against Boston Scientific Corporation (BSX), alleging the medical device giant made misleading statements regarding its clinical trials and business prospects. The litigation follows a period of heightened volatility for the company's cardiovascular portfolio, specifically concerning the FARAPULSE PFA system and recent trial adjustments.
Full story: https://gethealthbrief.com/story/boston-scientific-pomerantz-class-action-analysis

### Pomerantz LLP Initiates Securities Class Action Against Boston Scientific
2026-03-23 23:31:37 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has issued a formal notice regarding a class action lawsuit against Boston Scientific Corporation (BSX), alleging potential securities fraud. The litigation focuses on whether the medical technology giant made misleading statements regarding its product pipeline or regulatory compliance during the class period.
Full story: https://getlegalbrief.com/story/pomerantz-llp-boston-scientific-class-action-2026

### Pomerantz LLP Advances Securities Litigation Against Richtech and Mereo
2026-03-22 02:56:06 · Sector: startups · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Richtech Robotics and Mereo BioPharma, alleging securities fraud and misleading disclosures. These legal maneuvers highlight the increasing scrutiny on post-IPO startups and clinical-stage biotech firms facing market volatility.
Full story: https://getstartupbrief.com/story/pomerantz-llp-securities-litigation-richtech-mereo

### Pomerantz LLP Advances Class Action Against Mereo BioPharma Over Disclosures
2026-03-22 02:55:33 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has issued a formal reminder regarding a class-action lawsuit filed against Mereo BioPharma Group plc, alleging potential violations of federal securities laws. The legal action focuses on whether the company made misleading statements or failed to disclose material facts regarding its clinical operations and financial outlook.
Full story: https://getbiobrief.com/story/pomerantz-llp-mereo-biopharma-class-action

### Pomerantz LLP Targets Mereo BioPharma and Richtech Robotics in Class Actions
2026-03-22 02:54:59 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Mereo BioPharma and Richtech Robotics, signaling a surge in securities litigation within the biotech and automation sectors. These legal actions focus on alleged violations of federal securities laws, specifically regarding material misstatements that impacted investor valuations.
Full story: https://getlegalbrief.com/story/pomerantz-llp-securities-litigation-mreo-richtech

### Pomerantz LLP Targets Nektar and Enphase in New Securities Class Actions
2026-03-22 02:52:54 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has initiated class action litigation against Nektar Therapeutics and Enphase Energy, alleging securities fraud and misleading statements. These filings highlight a growing trend of legal scrutiny in the biotech and renewable energy sectors as companies navigate volatile market conditions and regulatory shifts.
Full story: https://getfinancebrief.com/story/pomerantz-llp-nektar-enphase-class-action-litigation

### Pomerantz LLP Initiates Securities Class Action Against Enphase Energy
2026-03-22 02:52:19 · Sector: climate · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has filed a class action lawsuit against solar technology leader Enphase Energy, alleging securities law violations following a period of significant stock volatility. The litigation marks a critical regulatory challenge for the renewable energy sector as it navigates a broader market downturn.
Full story: https://getclimatebrief.com/story/pomerantz-enphase-energy-class-action-litigation

### Pomerantz LLP Files Class Action Against Nektar Therapeutics Over Disclosures
2026-03-22 02:52:13 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has initiated class action litigation against Nektar Therapeutics, alleging the company made false or misleading statements regarding its clinical programs and business prospects. The lawsuit seeks to recover damages for investors following significant stock volatility linked to the company's oncology pipeline performance.
Full story: https://getbiobrief.com/story/nektar-therapeutics-class-action-litigation-pomerantz

### Pomerantz LLP Issues Shareholder Alerts for Apollo, Driven Brands, and CWH
2026-03-22 02:51:04 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has issued urgent alerts to investors regarding class action lawsuits against Driven Brands, Apollo, and Camping World Holdings. These legal actions focus on alleged securities fraud and failures to disclose material information, potentially impacting institutional and retail recovery efforts.
Full story: https://getfinancebrief.com/story/pomerantz-shareholder-alerts-apollo-driven-brands-cwh

### Pomerantz LLP Targets Nektar and Enphase in New Securities Class Actions
2026-03-22 02:45:17 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Full story: https://getlegalbrief.com/story/pomerantz-llp-nektar-enphase-class-action

### Pomerantz LLP Targets Driven Brands and Camping World in Securities Litigation
2026-03-22 02:44:39 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz LLP has issued a series of alerts to shareholders regarding potential class action lawsuits against Driven Brands, Camping World Holdings, and Apollo-affiliated entities. The litigation follows significant financial disclosures, including Driven Brands' admission of material errors in prior financial statements.
Full story: https://getlegalbrief.com/story/pomerantz-shareholder-suits-driven-brands-camping-world

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.